Products for Research Use Only
RegisterLogin

Girancitug

CAT: 0804-HY-P991689Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991689Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor targeting VEGFR2/KDR/CD309. Girancitug effectively inhibits angiogenesis. Girancitug can be used for anti-angiogenic therapy in cancers like colorectal and ovarian cancer research[1][2].
CAS Number
3024821-77-7
UNSPSC
12352100
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
References & Citations
[1]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .|[2]Wang X, et al. Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role. Front Cell Dev Biol. 2020 Nov 16;8:599281.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1

Alternative Products

CatalogName
T9901A-1900-01Girancitug
WA2917Research Grade girancitug
GTR18776741-01Research Grade girancitug Antibody
PX-TA2483-01Girancitug Biosimilar - Research Grade
HW338136-01Anti-Human VEGFR2/KDR/Flk-1 Reference Antibody (Girancitug, RUO)

Popular Products